🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Inspiratory Muscle Training in Patients With Inflammatory Myopathy

RecruitingNAAges 18 Years - anyAllJózef Piłsudski University of Physical Education
NCT07274267 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Inflammatory myopathies are rare autoimmune diseases leading to progressive muscle weakness, often including the respiratory muscles. This study aims to investigate whether inspiratory muscle training (IMT) using a threshold device can improve functional status in patients with inflammatory myopathy. Thirty-three patients will undergo a 3-month home-based IMT program with progressive resistance. Functional capacity, inspiratory muscle strength, lung function, diaphragmatic mobility, fatigue, and quality of life will be assessed at baseline and during follow-up. The primary hypothesis is that IMT will enhance inspiratory muscle strength and translate into better functional performance and quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of inflammatory myopathy according to European Alliance of Associations for Rheumatology / American College of Rheumatology criteria * Age ≥ 18 years * Stable clinical condition allowing participation in physical activity * Ability to understand and follow instructions * Written informed consent to participate in the study Exclusion Criteria: * Cognitive impairment preventing proper exercise performance * Current respiratory tract infection * Previous respiratory muscle training within the last 12 months * History of spontaneous pneumothorax * Pulmonary hypertension * Tympanic membrane rupture or other middle ear pathology * Lack of voluntary and informed consent
💊

What it tests

  • Inspiratory Muscle Training (IMT)
📍

Where

1 site
University Clinical Center of the Medical University of Warsaw
Warsaw, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy